Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Investors to Learn More About the Investigation
Portfolio Pulse from
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors in Sage Therapeutics, Inc. (NASDAQ:SAGE). The investigation targets those who purchased Sage securities before April 12, 2021, and still hold them.
January 07, 2025 | 3:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Sage Therapeutics, Inc. for investors who purchased securities before April 12, 2021. This could lead to legal challenges for the company.
The investigation by a law firm into potential claims against Sage Therapeutics could lead to legal challenges, affecting investor confidence and potentially impacting the stock price negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100